Chicago, IL, United States of America

Niharika Chauhan

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Abbvie Inc.. Active years: 2023.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Niharika Chauhan: Innovator in Pharmaceutical Compositions

Introduction

Niharika Chauhan is a prominent inventor based in Chicago, IL (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions. Her work is characterized by a commitment to advancing medical science and improving patient outcomes.

Latest Patents

Niharika holds 1 patent for her invention titled "Elagolix sodium compositions and processes." This patent relates to compositions of elagolix sodium, along with the processes and intermediates for its preparation. Her invention is a testament to her expertise and dedication to pharmaceutical innovation.

Career Highlights

Niharika is currently employed at AbbVie Inc., a leading global biopharmaceutical company. Her role at AbbVie allows her to work on cutting-edge research and development projects that aim to address unmet medical needs. Her contributions have been instrumental in the advancement of therapeutic solutions.

Collaborations

Throughout her career, Niharika has collaborated with notable colleagues, including Raimundo Ho and Albert Wayne Kruger. These collaborations have fostered a dynamic environment for innovation and have led to the successful development of new pharmaceutical products.

Conclusion

Niharika Chauhan is a remarkable inventor whose work in pharmaceutical compositions has the potential to make a significant impact on healthcare. Her dedication to innovation and collaboration exemplifies the spirit of advancement in the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…